Histologically, combined treatment with PPP and low dose of ASP3026 was associated with expanded areas of tumor cell necrosis, decreased proliferation index as evaluated by Ki-67 staining, and downregulation of phosphorylated IGF-IR and STAT3. The gene discussed is IGF1R; the disease is neoplasm.